Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/in/news-releases/kura-oncology-and-kyowa-kirin-announce-global-strategic-collaboration-to-develop-and-commercialize-ziftomenib-in-acute-leukemias-302312119.html

PR NEWSWIRE
21 Nov 2024

https://www.globenewswire.com//news-release/2024/10/24/2968596/35186/en/Kura-Oncology-Reports-Preclinical-Data-Supporting-Opportunity-for-Ziftomenib-in-Treatment-of-Gastrointestinal-Stromal-Tumors-GIST.html

GLOBENEWSWIRE
24 Oct 2024

https://www.globenewswire.com/en/news-release/2024/09/30/2955703/35186/en/Kura-Oncology-Announces-Publication-of-Ziftomenib-Phase-1-Results-in-The-Lancet-Oncology.html

GLOBENEWSWIRE
30 Sep 2024

https://www.globenewswire.com/news-release/2024/08/08/2926821/35186/en/Kura-Oncology-Announces-FDA-Clearance-of-IND-Application-for-Menin-Inhibitor-Ziftomenib-in-Advanced-Gastrointestinal-Stromal-Tumors-GIST.html

GLOBENEWSWIRE
08 Aug 2024

https://www.globenewswire.com/news-release/2024/06/24/2902881/35186/en/Kura-Oncology-Reports-Preclinical-Data-Supporting-Potential-for-Menin-Inhibitor-in-Diabetes.html

GLOBENEWSWIRE
24 Jun 2024

https://www.globenewswire.com/news-release/2024/05/14/2881267/35186/en/Kura-Oncology-Completes-Enrollment-in-Registration-Directed-Trial-of-Ziftomenib-in-NPM1-Mutant-AML.html

GLOBENEWSWIRE
14 May 2024